{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T10:01:19Z","timestamp":1792144879698,"version":"4.4.0"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"3","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01NS073884"],"award-info":[{"award-number":["1R01NS073884"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R21MH073624"],"award-info":[{"award-number":["1R21MH073624"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPSP"],"published-print":{"date-parts":[[2021,12,14]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>During Lucid Dreams, the dreamer is aware, experiences the dream as if fully awake,\nand may control the dream content. The dreamer can start, stop, and restart dreaming, depending\non the nature and pleasantness of the dream. For patients with Reward Deficiency Syndrome (RDS)\nbehaviors, like Attention Deficit Hyperactivity Disorder (ADHD), Tourette&amp;#039;s-Syndrome, and\nPosttraumatic Stress Disorder (PTSD), the dream content may be pleasant, unpleasant, or terrifying.\nA sample of psychiatric center patients identified as having RDS reported the effectiveness of\na neuronutrient, dopamine agonist, KB200Z, in combating terrifying, lucid dreaming. These reports\nmotivated the study of eight clinical cases with known histories of substance abuse, childhood\nabuse, and PTSD. The administration of KB200Z, associated with eliminating unpleasant or\nterrifying lucid dreams in 87.5% of the cases. Subsequently, other published cases have further\nestablished the possibility of the long-term elimination of terrifying dreams in PTSD and ADHD\npatients. Induction of dopamine homeostasis may mitigate the effects of neurogenetic and epigenetic\nchanges in neuroplasticity, identified in the pathogenesis of PTSD and ADHD. The article explores\nhow relief of terrifying lucid dreams may benefit from modulation of dopaminergic signaling\nactivated by the administration of a neuronutrient. Recently, precision formulations of the\nKB220 neuronutrient guided by Genetic Addiction Risk Severity (GARS) test results have been\nused to repair inheritable deficiencies within the brain reward circuitry. The proposition is that improved\ndopamine transmodulational signaling may stimulate positive cognitive recall and subsequently\nattenuate the harmful epigenetic insults from trauma.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/2211556010666210215153513","type":"journal-article","created":{"date-parts":[[2021,2,16]],"date-time":"2021-02-16T05:08:06Z","timestamp":1613452086000},"page":"170-180","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Epigenetic Repair of Terrifying Lucid Dreams by Enhanced Brain Reward Functional Connectivity and Induction of Dopaminergic Homeo - static Signaling"],"prefix":"10.2174","volume":"10","author":[{"given":"Kenneth","family":"Blum","sequence":"first","affiliation":[{"name":"Western University Health Sciences, Pomona, CA, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"McLaughlin","sequence":"additional","affiliation":[{"name":"Center for Psychiatric Medicine, Laurence, MA, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward J.","family":"Modestino","sequence":"additional","affiliation":[{"name":"Department of Psychology, Curry College, Milton, MA, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Baron","sequence":"additional","affiliation":[{"name":"Department Psychiatry, Wright University, Boonshoff School of Medicine, Dayton, OH, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdalla","family":"Bowirrat","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology and Adelson School of Medicine, Ariel University, Ariel 40700, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Brewer","sequence":"additional","affiliation":[{"name":"Division of Nutrigenomics, Geneus Genomic Testing Center, Geneus Health, LLC., San Antonio, TX, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Steinberg","sequence":"additional","affiliation":[{"name":"Department of Psychology, Curry College, Milton, MA, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alphonso K.","family":"Roy","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, School of Medicine, University of Tulane, New Orleans, LA, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo","family":"Febo","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, McKnight Brain Institute, University of Florida, School of Medicine, Gainesville, FL, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajendra D.","family":"Badgaiyan","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Ichan School of Medicine, Mount Sinai Hospital, New York, NY, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marks S.","family":"Gold","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Washington University School of Medicine, St. Louis, Mo, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Current Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/191427","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/191427\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/191427","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,18]],"date-time":"2021-12-18T16:48:19Z","timestamp":1639846099000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/191427\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,14]]},"references-count":0,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,12,14]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/2211556010666210215153513","relation":{},"ISSN":["2211-5560"],"issn-type":[{"value":"2211-5560","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12,14]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-09-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-24","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-29","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}